Results 181 to 190 of about 173,141 (216)

A Case of HBV-Induced Liver Failure in the REEF-2 Phase II Trial: Implications for Finite Treatment Strategies in HBV ‘Cure’

Journal of Hepatology, 2022
Ivana Carey, James Lok, Kosh Agarwal
exaly  

396 STUDY OF HBV (RE)INFECTION IN THE COURSE OF LIVER TRANSPLANTATION IN HBV, HBV/HDV AND OCCULT HBV INFECTED PATIENTS

Journal of Hepatology, 2013
T. Pollicino, L. Caccamo, M.F. Donato, G. Raffa, G. Rossi, G. Raimondo   +5 more
openaire   +1 more source

HBV vaccines and methods treating HBV

2022
BALSITIS SCOTT J, AHMADI-ERBER SARAH M, SCHIPPERS TIMO, SCHMIDT SARAH   +3 more
openaire   +3 more sources

Retrospective and Prospective Studies of Hepatitis B Virus Reactivation in Malignant Lymphoma With Occult HBV Carrier

Annals of Oncology, 2009
E Sueoka, M Ide, T Mizuta
exaly  

Rituximab-Associated Hepatitis B Virus (HBV) Reactivation in Lymphoproliferative Diseases: Meta-Analysis and Examination of FDA Safety Reports

Annals of Oncology, 2011
Yu-Chieh Su, Andrew M Evens, D W Raisch
exaly  

Engineering Virus-Specific T Cells That Target HBV Infected Hepatocytes and Hepatocellular Carcinoma Cell Lines

Journal of Hepatology, 2011
Mala K Maini, Antonio Bertoletti, Christiane Ruedl   +2 more
exaly  

A Mouse Model for HBV Immunotolerance and Immunotherapy

Cellular and Molecular Immunology, 2014
Yang-Xin Fu, Lishan Su, Hua Peng
exaly  

An HBV-Encoded miRNA Activates Innate Immunity to Restrict HBV Replication.

Journal of Molecular Cell Biology, 2020
Min Liu, Lu Sun, Hong Xie
exaly  

[HBV--clinical impact of HBV genotypes].

Nihon rinsho. Japanese journal of clinical medicine, 2003
Yasuhito, Tanaka, Masashi, Mizokami
openaire   +1 more source

Exosomes Mediate Hepatitis B Virus (HBV) Transmission and NK-Cell Dysfunction

Cellular and Molecular Immunology, 2017
Jian Zhang, Yinli Yang, Cai Zhang
exaly